Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2019 |
| Author/s |
author: Rama Krishna Nimmakayala |
| Publication date | June 18, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |